Purple Biotech Ltd. (PPBT) Tops Q2 EPS by 1c

Purple Biotech Ltd. (NASDAQ: PPBT) reported Q2 EPS of ($0.25), $0.01 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Purple Biotech Ltd. (PPBT) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• The LGL Group (LGL) Misses Q2 EPS by 8c
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c